SCHEMBL1901737

SCHEMBL1901737

O=C(O)c1cc2ccc3cccc4ccc(c1)c2c34

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 1.00
KMT2A Q03164 3/20 1.00
TSHR P16473 4/20 0.50
HSD17B10 Q99714 3/20 0.50
CA12 O43570 3/20 0.50
CA9 Q16790 3/20 0.50
ALDH1A1 P00352 3/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CYP1A1 P04798 2/20 0.50
CYP1B1 Q16678 2/20 0.50
RNASEH1 O60930 1/20 0.50
PTPN11 Q06124 1/20 0.50
GPR35 Q9HC97 1/20 0.50
ATG4B Q9Y4P1 1/20 0.50
PTPN1 P18031 1/20 0.50
CA6 P23280 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
HPGD P15428 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1403567 0.91 MEN1 (0.82) MEN1KMT2ATSHRHSD17B10CA12
SCHEMBL21713201 0.88 MEN1 (0.78) MEN1KMT2ATSHRHSD17B10CA12
SCHEMBL22345884 0.86 KMT2A (0.73) MEN1KMT2ATSHRHSD17B10CA12
Pyrene SCHEMBL28702311 0.85 MEN1 (0.74) MEN1KMT2AHSD17B10CA12CA9
Pyrene SCHEMBL21625028 0.84 MEN1 (0.72) MEN1KMT2ATSHRHSD17B10CA12
Pyrene SCHEMBL21056192 0.84 MEN1 (0.72) MEN1KMT2ATSHRHSD17B10CA12
SCHEMBL13960184 0.84 MEN1 (0.72) MEN1KMT2ATSHRHSD17B10CA12
SCHEMBL13523688 0.83 MEN1 (0.69) MEN1KMT2ATSHRHSD17B10CA12
SCHEMBL32681078 0.82 MEN1 (0.69) MEN1KMT2ATSHRHSD17B10CA12
SCHEMBL13960185 0.82 MEN1 (0.69) MEN1KMT2ATSHRHSD17B10CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12421447-B2 Fluorescent metal organic frameworks (MOFs) for drilling depth correlation and waterfront mapping SAUDI ARABIAN OIL COMPANY (SA) 2025-09-23 US claimed
CN-119570059-B Mn-PTO (Mn-PTO) anode material of metal organic framework sodium ion battery, preparation method and application 南京工业大学 2025-06-03 CN claimed
CN-119899306-A Resin for high extinction coefficient anti-reflection coating and preparation method thereof 苏州威迈芯材半导体有限公司 2025-04-29 CN claimed
EP-4536933-A1 FLUORESCENT METAL-ORGANIC FRAMEWORKS Saudi Arabian Oil Company (SA) 2025-04-16 EP claimed
CN-119570059-A Mn-PTO (Mn-PTO) anode material of metal organic framework sodium ion battery, preparation method and application 南京工业大学 2025-03-07 CN claimed
CN-119497781-A Fluorescent metal-organic frameworks 沙特阿拉伯石油公司 2025-02-21 CN claimed
CN-119220251-A Method for synthesizing aqueous phase multicolor organic afterglow nano material in large quantity by one-pot method 浙江工业大学 2024-12-31 CN claimed
US-20240294824-A1 FLUORESCENT METAL ORGANIC FRAMEWORKS (MOFS) FOR DRILLING DEPTH CORRELATION AND WATERFRONT MAPPING SAUDI ARABIAN OIL COMPANY (SA) 2024-09-05 US claimed
WO-2023239252-A1 FLUORESCENT METAL-ORGANIC FRAMEWORKS SAUDI ARABIAN OIL COMPANY (SA) 2023-12-14 WO claimed
EP-3727435-B1 BIVALENT NUCLEIC ACID LIGANDS AND USES THEREFOR UNIV CARNEGIE MELLON (US) 2026-02-18 EP disclosed
US-20250376619-A1 FLUORESCENT METAL ORGANIC FRAMEWORKS (MOFS) FOR DRILLING DEPTH CORRELATION AND WATERFRONT MAPPING SAUDI ARABIAN OIL COMPANY (SA) 2025-12-11 US disclosed
US-12421447-B2 Fluorescent metal organic frameworks (MOFs) for drilling depth correlation and waterfront mapping SAUDI ARABIAN OIL COMPANY (SA) 2025-09-23 US disclosed
CN-119899306-A Resin for high extinction coefficient anti-reflection coating and preparation method thereof 苏州威迈芯材半导体有限公司 2025-04-29 CN disclosed
EP-4536933-A1 FLUORESCENT METAL-ORGANIC FRAMEWORKS Saudi Arabian Oil Company (SA) 2025-04-16 EP disclosed
US-20110177619-A1 IN VITRO DIAGNOSTIC MARKERS COMPRISING CARBON NANOPARTICLES AND KITS PITLAB LTD (GB) 2011-07-21 US disclosed
EP-2318051-A2 IN VITRO DIAGNOSTIC MARKERS COMPRISING CARBON NANOPARTICLES AND KITS Metters, Andrew (US) 2011-05-11 EP disclosed
WO-2010008519-A2 IN VITRO DIAGNOSTIC MARKERS COMPRISING CARBON NANOPARTICLES AND KITS METTERS ANDREW (US) 2010-01-21 WO disclosed
EP-1373872-A4 METHOD AND APPARATUS FOR DETECTING AND QUANTIFYING A CHEMICAL SUBSTANCE EMPLOYING A SPECTRAL PROPERTY OF METALLIC ISLANDS YEDA RES & DEV (IL) 2009-04-22 EP disclosed
EP-1373872-A1 METHOD AND APPARATUS FOR DETECTING AND QUANTIFYING A CHEMICAL SUBSTANCE EMPLOYING A SPECTRAL PROPERTY OF METALLIC ISLANDS YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD. (IL) 2004-01-02 EP disclosed
WO-2002068943-A1 METHOD AND APPARATUS FOR DETECTING AND QUANTIFYING A CHEMICAL SUBSTANCE EMPLOYING A SPECTRAL PROPERTY OF METALLIC ISLANDS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2002-09-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110177619-A1 IN VITRO DIAGNOSTIC MARKERS COMPRISING CARBON NANOPARTICLES AND KITS CD63, LGALS3, MKI67 MEN1 2546/4885KMT2A 3353/4885TSHR 4160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.